載入...
Pre-TCRα supports CD3-dependent reactivation and expansion of TCRα-deficient primary human T-cells
Chimeric antigen receptor technology offers a highly effective means for increasing the anti-tumor effects of autologous adoptive T-cell immunotherapy, and could be made widely available if adapted to the use of allogeneic T-cells. Although gene-editing technology can be used to remove the alloreact...
Na minha lista:
| 發表在: | Mol Ther Methods Clin Dev |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Nature Publishing Group
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4362381/ https://ncbi.nlm.nih.gov/pubmed/26015965 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mtm.2014.21 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|